Lounis, M.A.; Péant, B.; Leclerc-Desaulniers, K.; Ganguli, D.; Daneault, C.; Ruiz, M.; Zoubeidi, A.; Mes-Masson, A.-M.; Saad, F.
Modulation of de Novo Lipogenesis Improves Response to Enzalutamide Treatment in Prostate Cancer. Cancers 2020, 12, 3339.
https://doi.org/10.3390/cancers12113339
AMA Style
Lounis MA, Péant B, Leclerc-Desaulniers K, Ganguli D, Daneault C, Ruiz M, Zoubeidi A, Mes-Masson A-M, Saad F.
Modulation of de Novo Lipogenesis Improves Response to Enzalutamide Treatment in Prostate Cancer. Cancers. 2020; 12(11):3339.
https://doi.org/10.3390/cancers12113339
Chicago/Turabian Style
Lounis, Mohamed Amine, Benjamin Péant, Kim Leclerc-Desaulniers, Dwaipayan Ganguli, Caroline Daneault, Matthieu Ruiz, Amina Zoubeidi, Anne-Marie Mes-Masson, and Fred Saad.
2020. "Modulation of de Novo Lipogenesis Improves Response to Enzalutamide Treatment in Prostate Cancer" Cancers 12, no. 11: 3339.
https://doi.org/10.3390/cancers12113339
APA Style
Lounis, M. A., Péant, B., Leclerc-Desaulniers, K., Ganguli, D., Daneault, C., Ruiz, M., Zoubeidi, A., Mes-Masson, A. -M., & Saad, F.
(2020). Modulation of de Novo Lipogenesis Improves Response to Enzalutamide Treatment in Prostate Cancer. Cancers, 12(11), 3339.
https://doi.org/10.3390/cancers12113339